Ibodutant
id:
ibodutant-277-6749844
title:
Ibodutant
text:
Ibodutant was a candidate drug for irritable bowel syndrome diarrhea, developed by The Menarini Group. As of March 2015, it underwent a multicentre double blind efficacy clinical study. Ibodutant selectively blocks the tachykinin receptor NK2, with blockade practically complete in nanomolar concentrations. A phase 2 trial in Europe completed in May 2012 with positive results. A 52-week phase 3 study was terminated as of 2015 because of low response and negative results of study NAK-06.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ibodutant
date created:
date modified:
2022-03-05T22:44:27Z
main entity:
{"identifier":"Q5984345","url":"https://www.wikidata.org/entity/Q5984345"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/bb/Ibodutant_structure.svg","width":195,"height":431}
fields total:
13
integrity:
15